Form 8-K - Current report:
SEC Accession No. 0001178879-20-000029
Filing Date
2020-07-17
Accepted
2020-07-17 07:33:45
Documents
16
Period of Report
2020-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fold-20200717.htm   iXBRL 8-K 45266
2 EX-99.1 a9911.htm EX-99.1 16887
8 GRAPHIC image01.jpg GRAPHIC 45596
  Complete submission text file 0001178879-20-000029.txt   275196

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20200717.xsd EX-101.SCH 2466
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20200717_cal.xml EX-101.CAL 742
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20200717_def.xml EX-101.DEF 1679
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20200717_lab.xml EX-101.LAB 24266
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20200717_pre.xml EX-101.PRE 12678
9 EXTRACTED XBRL INSTANCE DOCUMENT fold-20200717_htm.xml XML 11251
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 201032756
SIC: 2834 Pharmaceutical Preparations